Mangalam Drugs
Company Overview - January 14, 2025
Mangalam Drugs is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on both the BSE (Code: 532637) and NSE (Code: MANGALAM). As of the January 14, 2025, the company holds a market capitalization of INR 198.98 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 125.70, Mangalam Drugs has demonstrated a 8.91% return over the last year. Recent performance indicates fluctuations, with a 1.58% change in the past week and a -4.36% change over the last month. The company's all-time high stands at INR 442.40, while its lowest-ever price was INR 3.43.
In terms of sales, Mangalam Drugs reported a revenue of INR 356.05 crores, solidifying its position in the market. The average trading volume over the past month has been 16631 shares, with a more recent weekly average of 15508.
With the stock trading above its 50-day moving average of INR 113.04, the company's technical indicators like MACD (-2.63) signal positive trends.
Company Data
| Name | Mangalam Drugs |
|---|---|
| BSE Code | 532637 |
| NSE Code | MANGALAM |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 125.70 |
| Market Capitalization | 198.98 |
| Sales | 356.05 |
| Return over 3months | -16.21 |
| Return over 6months | 5.31 |
| Volume 1month average | 16631 |
| Volume 1week average | 15508 |
| Volume | 17762 |
| High price | 144.99 |
| Low price | 85.16 |
| High price all time | 442.40 |
| Low price all time | 3.43 |
| Return over 1day | 17.37 |
| Return over 1week | 1.58 |
| Return over 1month | -4.36 |
| Return over 1year | 8.91 |
| Return over 3years | -4.65 |
| Return over 5years | 29.40 |
| Volume 1year average | 101388 |
| DMA 50 | 113.04 |
| DMA 200 | 112.75 |
| DMA 50 previous day | 113.30 |
| DMA 200 previous day | 112.81 |
| MACD | -2.63 |
| MACD Signal | -3.09 |